Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc Girard

Showing results (81-90 of 192) with videos related to

Pageof 20
Sort By:
Cancer Science|November 24, 2012
TIMELESS is overexpressed in lung cancer and its expression correlates with poor patient survivalKenya Yoshida, Mitsuo Sato, Tetsunari Hase, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2014
Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathwayChunli Shao, James P Sullivan, Luc Girard, et al.
Molecular Endocrinology (Baltimore, Md.)|June 16, 2012
Research resource: Diagnostic and therapeutic potential of nuclear receptor expression in lung cancerYangsik Jeong, Yang Xie, Woochang Lee, et al.
Cancer Research|November 4, 2011
SMAC mimetic (JP1201) sensitizes non-small cell lung cancers to multiple chemotherapy agents in an IAP-dependent but TNF-α-independent mannerRachel M Greer, Michael Peyton, Jill E Larsen, et al.
Cancer Research|October 5, 2006
The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatin-induced resistance in human non-small-cell lung cancer cellsKentaro Ueda, Hiroyuki Kawashima, Shoichiro Ohtani, et al.
International Journal of Cancer|May 6, 2011
Oncogenic KRAS-induced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancerNoriaki Sunaga, Hisao Imai, Kimihiro Shimizu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2002
Methylation profiles of sporadic ovarian tumors and nonmalignant ovaries from high-risk womenAsha Rathi, Arvind K Virmani, John O Schorge, et al.
Cancer Research|June 28, 2017
GLI1 Blockade Potentiates the Antitumor Activity of PI3K Antagonists in Lung Squamous Cell CarcinomaSahba Kasiri, Chunli Shao, Baozhi Chen, et al.
Cancer Research|February 21, 2006
Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cellsMitsuo Sato, Melville B Vaughan, Luc Girard, et al.
Cancer Research|March 13, 2012
The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARAAndrea Rabellino, Brandon Carter, Georgia Konstantinidou, et al.
Pageof 20

Showing results (81-90 of 192) with videos related to

Sort By:
Pageof 20
Cancer Science|November 24, 2012
TIMELESS is overexpressed in lung cancer and its expression correlates with poor patient survivalKenya Yoshida, Mitsuo Sato, Tetsunari Hase, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2014
Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathwayChunli Shao, James P Sullivan, Luc Girard, et al.
Molecular Endocrinology (Baltimore, Md.)|June 16, 2012
Research resource: Diagnostic and therapeutic potential of nuclear receptor expression in lung cancerYangsik Jeong, Yang Xie, Woochang Lee, et al.
Cancer Research|November 4, 2011
SMAC mimetic (JP1201) sensitizes non-small cell lung cancers to multiple chemotherapy agents in an IAP-dependent but TNF-α-independent mannerRachel M Greer, Michael Peyton, Jill E Larsen, et al.
Cancer Research|October 5, 2006
The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatin-induced resistance in human non-small-cell lung cancer cellsKentaro Ueda, Hiroyuki Kawashima, Shoichiro Ohtani, et al.
International Journal of Cancer|May 6, 2011
Oncogenic KRAS-induced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancerNoriaki Sunaga, Hisao Imai, Kimihiro Shimizu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2002
Methylation profiles of sporadic ovarian tumors and nonmalignant ovaries from high-risk womenAsha Rathi, Arvind K Virmani, John O Schorge, et al.
Cancer Research|June 28, 2017
GLI1 Blockade Potentiates the Antitumor Activity of PI3K Antagonists in Lung Squamous Cell CarcinomaSahba Kasiri, Chunli Shao, Baozhi Chen, et al.
Cancer Research|February 21, 2006
Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cellsMitsuo Sato, Melville B Vaughan, Luc Girard, et al.
Cancer Research|March 13, 2012
The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARAAndrea Rabellino, Brandon Carter, Georgia Konstantinidou, et al.
Pageof 20